| 1 |
28630069 | Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4. | 2017 Sep |
1 |
| 2 |
21510839 | Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein. | 2011 |
2 |
| 3 |
20061446 | Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand. | 2010 Apr |
2 |
| 4 |
20799012 | Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors. | 2010 Aug |
1 |
| 5 |
17676345 | 3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment. | 2007 Oct |
1 |
| 6 |
16621806 | NMR and alanine scan studies of glucose-dependent insulinotropic polypeptide in water. | 2006 Jun 16 |
5 |
| 7 |
15955806 | A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis. | 2005 Aug 5 |
1 |
| 8 |
15302229 | In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide. | 2004 Aug 27 |
2 |
| 9 |
12800091 | Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in vivo. | 2003 Jun |
2 |
| 10 |
14617798 | Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics. | 2003 Nov |
1 |
| 11 |
8100523 | Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. | 1993 Jun 15 |
2 |